Drug profile · INN
haloprogin
HALOTEX
haloprogin (HALOTEX) is a cell membrane inhibitor. Route of administration: topical. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — haloprogin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
haloprogin (HALOTEX) is a cell membrane inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN haloprogin
Brand HALOTEX
Mechanism Cell membrane inhibitor
Target Cell membrane
Route TOPICAL
Formulation SOLUTION
Mechanism of action
Cell membrane inhibitor
Primary target: Cell membrane
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is haloprogin?
haloprogin (HALOTEX) is a cell membrane inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for haloprogin?
HALOTEX is a marketed brand name for haloprogin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of haloprogin?
haloprogin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.